TY  - GEN
AU  - Oehler,Vivian G
AU  - Radich,Jerald P
TI  - Monitoring BCR-ABL in the treatment of chronic myeloid leukemia by polymerase chain reaction
SN  - 1558-822X
PY  - 2010///0806
KW  - Adult
KW  - Antineoplastic Agents
KW  - therapeutic use
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Benzamides
KW  - Biomarkers, Tumor
KW  - blood
KW  - Bone Marrow Transplantation
KW  - methods
KW  - Child
KW  - Clinical Trials as Topic
KW  - Combined Modality Therapy
KW  - Disease-Free Survival
KW  - Drug Monitoring
KW  - Drug Resistance, Neoplasm
KW  - genetics
KW  - Fusion Proteins, bcr-abl
KW  - antagonists & inhibitors
KW  - Humans
KW  - Imatinib Mesylate
KW  - Leukemia, Myelogenous, Chronic, BCR-ABL Positive
KW  - Multicenter Studies as Topic
KW  - Neoplasm, Residual
KW  - Piperazines
KW  - administration & dosage
KW  - Polymerase Chain Reaction
KW  - Protein Kinase Inhibitors
KW  - Pyrimidines
KW  - Recurrence
KW  - Sensitivity and Specificity
N1  - Publication Type: Journal Article; Review
UR  - https://doi.org/10.1007/s11899-996-0003-x
ER  -